Clinical Trial: Spirulina-Derived Product Alleviates Oral Mucositis in Patients Undergoing Radiotherapy for Malignant Head and Neck Tumors

U.S., June 28 -- ClinicalTrials.gov registry received information related to the study (NCT07040969) titled 'Spirulina-Derived Product Alleviates Oral Mucositis in Patients Undergoing Radiotherapy for Malignant Head and Neck Tumors' on June 19.

Brief Summary: To evaluate the efficacy and safety of Spirulina-Derived Product for prevention and treatment of oral mucositis in patients undergoing radiotherapy for malignant head and neck tumors.

Study Start Date: June 24

Study Type: INTERVENTIONAL

Condition: Radiation-induced Oral Mucositis

Intervention: DRUG: Spray of spirulina derivatives

An oral spray formulated with purified spirulina-derived exosomes.

DRUG: Spray of placebo

The placebo oral spray will be formulated with inactive in...